←
PitarresiPhD1,081 posts
PitarresiPhD avatar

PitarresiPhD

@PitarresiLab

Jason R. Pitarresi. Father. Studying pancreatic cancer, cellular plasticity/metastasis, and tumor-host interactions. @pitarresilab.bsky.social

◷ Joined February 2021▧ 147 Photos and videos
PitarresiPhD avatar
PitarresiPhD@PitarresiLab·7 Jun 2025

I'm excited to share the lab’s new paper on PDAC-associated cachexia on bioRxiv today, led by star postdoc @Nikita2106 Pancreatic cancer cachexia is mediated by PTHrP-driven disruption of adipose de novo lipogenesis A 🧵 below, if you're interested... biorxiv.org/content/10.1101/…

Post attachment
Tony Hui avatar
⟳ PitarresiPhD retweeted
Tony Hui@realTonyHui·Nov 3

Happy to report a rigorously controlled, comprehensively characterized mouse model in which cachexia is driven specifically by lung metastases, paired with a genetically identical, non-cachectic control group. Hope cachexia researchers find it useful. biorxiv.org/content/10.64898…

PitarresiPhD avatar
PitarresiPhD@PitarresiLab·Oct 7

Another successful @UMassChan Cancer Center Retreat in the books! Congrats to Paula Vo for winning a best poster award and Calvin Johnson for being selected for a talk!

Post attachmentPost attachment
PitarresiPhD avatar
PitarresiPhD@PitarresiLab·Sep 23

An absolutely beautiful study in Nature Cancer by the Chio lab on a novel mechanism of adipose tissue wasting in pancreatic cancer. Congrats to Christine, first author Jung Seung Nam, and the rest of the @Chiolaboratory!

Very happy to share our new paper in Nature Cancer. This project started with a simple question: what drives the early loss of adipose tissue during pancreatic cancer cachexia?

Marcus Ruscetti Lab avatar
⟳ PitarresiPhD retweeted
Marcus Ruscetti Lab@Marcus_Ruscetti·Sep 23

Happy to see our recent paper from @linzhou0515 online at @CR_AACR. Here we tested a panel of senescence-inducing therapies with different MoAs to uncover their unique SASP profiles and impact on immunity, and from that design effective senolytic approaches to block metastasis.

Now online: Senolytic Interventions Enhance the Anti-metastatic Activity of Chemotherapy in Prostate Cancer doi.org/10.1158/0008-5472.CA…

Post attachment
Marcus Goncalves avatar
⟳ PitarresiPhD retweeted
Marcus Goncalves@MarcusDGon·Sep 21

Quantitative in vivo flux analysis reveals tumor and host lipogenic remodeling in KRAS-driven lung cancer link.springer.com/article/10…

Yumi Kim (김유미) avatar
⟳ PitarresiPhD retweeted
Yumi Kim (김유미)@Yumi_Kim0201·Sep 13

Excited to see our work published in @ScienceAdvances! 🎉 Very grateful to Gina DeNicola (@LabDeNicola) and all our coauthors who made this work possible. 🔗 science.org/doi/10.1126/scia…

PitarresiPhD avatar
PitarresiPhD@PitarresiLab·Sep 3

I am very grateful to @NIH staff for their support and efforts in helping us secure this R56 award from the NCI I'm especially appreciative of my PO for championing our work on a novel driver of pancreatic cancer metastasis that has revealed exciting therapeutic vulnerabilities!

Post attachment
Anirban Maitra avatar
⟳ PitarresiPhD retweeted
Anirban Maitra@Aiims1742·Aug 14

Important changes coming to how @NIH reports scores on reviewed grants - while individual reviewers will still provide an overall impact score, the investigators will only receive information on which of three broader categories their grant falls under: grants.nih.gov/grants/guide/…

Post attachment
PitarresiPhD avatar
PitarresiPhD@PitarresiLab·Aug 12

Congrats to Nikita Bhalerao in the lab on being promoted to Instructor @UMassChan last month! She is entering the academic job market this year and will come with her own funding (Early K99/R00). Search committees, be on the lookout for this stellar candidate. Congrats Nikita!

Post attachment
Marcus Ruscetti Lab avatar
⟳ PitarresiPhD retweeted
Marcus Ruscetti Lab@Marcus_Ruscetti·Aug 12

Congrats to @ChaitanyaParik on his innovative and impactful work in the lab! Be on a look out for this rising star and his company, ImmunoScript, in the biotech space! Hope to see this therapy in patients one day.

A potentially transformative mRNA immunotherapy developed at @UMassChan eliminated pancreatic cancer tumors in 50 percent of treated mice models. Read about the research, published in @NatureComms: bit.ly/4g7Y30z #PancreaticCancer @ChaitanyaParik @Marcus_Ruscetti @theNCI